Evidence map›Paper›PMID 37280414›Full record

ArticleAdvances in therapy2023

SABAs as Reliever Medications in Asthma Management: Evidence-Based Science.

Israel Amirav, Gabriel Garcia, Bao Khac Le, Paulina Barria, Gur Levy, Bhumika Aggarwal, Kyle Fahrbach, Amber Martin, Abhay Phansalkar, Thitiwat Sriprasart

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07140458 (Comparative Effect of Box Breathing And Buteyko Breathing on Pulmonary Functions in Asthma), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07140458 nacompletednot on this mapstarted 2024, after this paper: background citation

Comparative Effect of Box Breathing And Buteyko Breathing on Pulmonary Functions in Asthma

TypeinterventionalSponsorRiphah International UniversityRan2024 to 2025Enrolled36ConditionsAsthma (Diagnosis), Breathing ExercisesArmsButeyko Breathing, Box breathing
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Treatment of bronchial asthma - A simplified overview.Lung India : official organ of Indian Chest Society · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Israel AmiravPediatric Pulmonology Unit, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. amirav@ualberta.ca.ORCID 0000-0002-6917-5285
Gabriel GarciaServicio de Neumonología, Hospital Rossi La Plata, Buenos Aires, Argentina.
Bao Khac LeUniversity of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Paulina BarriaUnidad de Respiratorio, Hospital Clínico de la Fuerza Aérea de Chile, Santiago, Chile.
Gur LevyRespiratory Medical Emerging Markets, GSK, Ciudad de Panamá, Panamá.
Bhumika AggarwalEmerging Markets, GSK, Singapore, 139234, Singapore.
Kyle FahrbachEvidera, Waltham, MA, USA.
Amber MartinEvidera, Waltham, MA, USA.
Abhay PhansalkarEmerging Markets, GSK, Mumbai, India.
Thitiwat SriprasartFaculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of as-needed inhaled short-acting β

Indexed as

Anti-Asthmatic AgentsAsthmaAdministration, InhalationAdrenal Cortex HormonesHumansNebulizers and VaporizersAdrenal Cortex HormonesAnti-Asthmatic AgentsAs-needed relieverAsthma managementSABAScientific evidenceShort-acting β2-agonists

Identifiers

PMID37280414
PMCPMC10244083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.